ACM
HRMY icon

Aquatic Capital Management’s Harmony Biosciences HRMY Stock Holding History

Aquatic Capital Management’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-705
Closed -$19.7K – 1464
2026
Q1 		$19.7K Buy
+705
New +$23.1K ﹤0.01% 1240
2025
Q2 		– Sell
-7,997
Closed -$265K – 1371
2025
Q1 		$265K Sell
7,997
-3,130
-28% -$112K 0.01% 887
2024
Q4 		$383K Buy
+11,127
New +$382K 0.01% 782
2024
Q3 		– Sell
-1,800
Closed -$54.3K – 1321
2024
Q2 		$54.3K Sell
1,800
-3,100
-63% -$93.2K ﹤0.01% 999
2024
Q1 		$165K Buy
4,900
+2,100
+75% +$67.4K 0.01% 808
2023
Q4 		$90K Buy
+2,800
New +$78.2K ﹤0.01% 1024
2023
Q2 		– Sell
-11,300
Closed -$369K – 1514
2023
Q1 		$369K Buy
+11,300
New +$515K 0.02% 476

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Aquatic Capital Management's HRMY Position: Q2 2026 in Review

Aquatic Capital Management sold out of Harmony Biosciences (HRMY) in Q2 2026, closing a stake of 705 shares — an estimated $19.7K sold.

Aquatic Capital Management first reported a position in HRMY in Q1 2023 and held it in 7 quarters. The position peaked at $383K in Q4 2024. 327 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Aquatic Capital Management reported no remaining Harmony Biosciences position as of Q2 2026 after selling out during the quarter.
  • Aquatic Capital Management sold 705 Harmony Biosciences shares in Q2 2026, an estimated $19.7K.
  • Aquatic Capital Management first reported a position in Harmony Biosciences in Q1 2023 and held it in 7 quarters.
  • Aquatic Capital Management's Harmony Biosciences position peaked at $383K in Q4 2024.
  • 327 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Aquatic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.